• Loading stock data...
PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » Johnson & Johnson stocks rose 2% despite landmark ruling on Oklahoma opioid crisis

Johnson & Johnson stocks rose 2% despite landmark ruling on Oklahoma opioid crisis

Al Restar by Al Restar
August 28, 2019
in Medical
2 min read
41
0
Johnson & Johnson stocks rose 2% despite landmark ruling on Oklahoma opioid crisis

Photo: Ajay Suresh | Flickr | CC BY 2.0

After an Oklahoma judge ruled against Johnsons and Johnsons on the opioid crisis case versus the company and imposed fines that are less than what investors are expecting, J&J stocks spiked up 2% in Tuesday’s post-market trading after the verdict was read.

Investors are expecting J&J to be fined between $500 million and $5 billion, reports revealed. However, the court only imposed a fine of $572 million.

Calling the opioid crisis an “imminent danger and menace,” District Judge Thad Balkman said, “the state met its burden that the defendants Janssen and Johnson & Johnson’s misleading marketing and promotion of opioids created a nuisance as defined by [the law],” highlighting that the opioid crisis has put the health of Oklahomans at risk.

“Specifically, defendants caused an opioid crisis that’s evidenced by increased rates of addiction, overdose deaths, and neonatal abstinence syndrome,” he added.

J&J said that they would file an appeal against the decision.

The case revolves around the allegations that J&J and its subsidiary company, Janssen, downplayed the risks of addiction to opioids. The suit alleges that the companies are training their sales representative to disclose to physicians that the risk was 2.6% or less if the drugs were prescribed by a doctor, leading doctors to prescribe huge amounts to their patients.

The fine that is to be paid by the company will be used by the state to fight against the effects of the opioid crisis for the first year. While the attorney general’s office has presented several expert witnesses that the rehabilitation program would be more likely to take more than 20 years, the court disagreed and said that there is no enough evidence to back this claim.

The state did not present sufficient evidence of the amount of time and costs necessary, beyond year one, to abate the opioid crisis,” the ruling says.

Al Restar

Al Restar

An idealist straight from business school who works as a content marketer, digital branding consultant, and graphic designer. Outside work, he spends his time taking care of his cacti and painting watercolors.

Related Posts

Regeneron buy back shares from Sanofi
Medical

Regeneron to buy back $5 billion shares from Sanofi

May 25, 2020
132
A report reveals that China is deliberately faking the number of COVID-19 cases and deaths.
General

China is underreporting COVID-19 cases, U.S. intelligence community says

April 1, 2020
151
Around the world, the total number of confirmed coronavirus infection went beyond 600,000, with 28,964 fatalities as of the latest report.
Medical

17% of all confirmed COVID-19 cases in the world comes from the US

March 28, 2020
138
President Donald Trump signed a $2 trillion coronavirus relief bill on Friday
General

Trump signs $2 trillion coronavirus relief

March 28, 2020
121
General Motors and Ventec Life Systems are partnering to convert the GM Kokomo, Indiana ERC building for the production of Ventec ventilators in response to the COVID-19 pandemic.
General

GM announces the start of production of critical-care ventilators shortly after Trump’s tweets against CEO

March 27, 2020
132
Rep. Thomas Massie, R-Ky., tried to force a full yes or no vote on the measure, which could have delayed its passage by hours.
Finance

$2 trillion coronavirus stimulus package passed by the House amid efforts to delay voting by Massie

March 27, 2020
119
Currently Playing

Subscribe To Our Newsletter

Ad

PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2020 PublicWire.com

Navigate Site

  • About
  • #96576 (no title)
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • #370 (no title)

© Copyright 2020 PublicWire.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Public Wire Logo

Hello please subscribe to our newsletter to get up to date news weekly!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.